| 查看: 1622 | 回复: 4 | |||
[交流]
美国南密西西比大学 白逢伟教授课题组诚招病毒感染免疫方向的优秀硕博士(免学费)
|
|
Dr. Fengwei Bai’s laboratory in the Department of Biological Sciences at The University of Southern Mississippi (Hattiesburg, MS, USA) is look for a self-motived and hardworking Ph.D candidate to study the pathogensis of Zika virus, West Nile virus and dengue virus in mouse models, and to develop vaccines and anti-viral reagents. The Ph.D position will start from the fall semester 2018. Dr. Bai’s research is supported by grants from the NIH, American Heart Association and other funding agencies. The laboratory currently has three graduate students (two Ph.D and one master student). The lab research environment is very friendly, collaborative and productive. In last five years, Dr. Bai and his students published over 20 research articles in Journal of Immunology, Journal of Virology, Journal of Biological chemistry, Scientific Reports and etc.. Two recently graduated Ph.D students were recruited as postdoctoral fellows by the US National Aeronautics and Space Administration (NASA) and University of Chicago, respectively. The benefits of graduate students in the Department of Biological Sciences include tuition waiver, RA or TA support, and free health insurance. The basic qualification of a candidate must have a BS or a master degree in biology, medicine or other related fields with strong interests in study of Virology, Immunology and infectious diseases. For detail information regarding Dr. Bai’s research, please visit: https://www.usm.edu/biological-sciences/faculty/fengwei-bai Information regarding The University of Southern Mississippi: https://home.usm.edu Information regarding the city Hattiesburg: https://www.hattiesburgms.com Interested candidates please contact Dr. Fengwei Bai: Fengwei.bai@usm.edu |
» 猜你喜欢
291分调剂
已经有9人回复
调剂求收留
已经有34人回复
291 求调剂
已经有38人回复
22408 312求调剂
已经有17人回复
一志愿华中农业071010,320求调剂
已经有6人回复
290调剂生物0860
已经有41人回复
291求调剂
已经有3人回复
211本科材料化工求调剂
已经有23人回复
山东省基金2026
已经有9人回复
药学求调剂
已经有13人回复
2楼2017-11-04 02:51:50
3楼2017-11-04 19:57:34

4楼2017-11-06 17:14:34
5楼2017-11-09 03:32:27














回复此楼